Correction To: Time to Re-Engage Psychiatric Drug Discovery by Strengthening Confidence in Preclinical Psychopharmacology

Mark David Tricklebank,Trevor W. Robbins,Camilla Simmons,Erik H. F. Wong

DOI: https://doi.org/10.1007/s00213-021-05859-y

2021-01-01

Psychopharmacology

Abstract:correction to this paper has been published: https://doi.org/10.1007/s00213-021-05859-y

What problem does this paper attempt to address?

Time to Re-Engage Psychiatric Drug Discovery by Strengthening Confidence in Preclinical Psychopharmacology

Mark D. Tricklebank,Trevor W. Robbins,Camilla Simmons,Erik H.F. Wong

DOI: https://doi.org/10.1007/s00213-021-05787-x

2021-01-01

Abstract:There is urgent need for new medications for psychiatric disorders. Mental illness is expected to become the leading cause of disability worldwide by 2030. Yet, the last two decades have seen the pharmaceutical industry withdraw from psychiatric drug discovery after costly late-stage trial failures in which clinical efficacy predicted pre-clinically has not materialised, leading to a crisis in confidence in preclinical psychopharmacology.Based on a review of the relevant literature, we formulated some principles for improving investment in translational neuroscience aimed at psychiatric drug discovery.We propose the following 8 principles that could be used, in various combinations, to enhance CNS drug discovery: (1) consider incorporating the NIMH Research Domain Criteria (RDoC) approach; (2) engage the power of translational and systems neuroscience approaches; (3) use disease-relevant experimental perturbations; (4) identify molecular targets via genomic analysis and patient-derived pluripotent stem cells; (5) embrace holistic neuroscience: a partnership with psychoneuroimmunology; (6) use translational measures of neuronal activation; (7) validate the reproducibility of findings by independent collaboration; and (8) learn and reflect. We provide recent examples of promising animal-to-human translation of drug discovery projects and highlight some that present re-purposing opportunities.We hope that this review will re-awaken the pharma industry and mental health advocates to the opportunities for improving psychiatric pharmacotherapy and so restore confidence and justify re-investment in the field.
Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia

Xing-Jie Peng,Gang-Rui Hei,Ye Yang,Chen-Chen Liu,Jing-Mei Xiao,Yu-Jun Long,Jing Huang,Jing-Ping Zhao,Ren-Rong Wu

DOI: https://doi.org/10.3389/fpsyt.2022.1094791

IF: 4.7

2022-12-19

Frontiers in Psychiatry

Abstract:[This corrects the article DOI: 10.3389/fpsyt.2021.638773.].

psychiatry
Correction: Acevedo et al. Therapeutic Neurostimulation in Obsessive-Compulsive and Related Disorders: A Systematic Review. Brain Sci. 2021, 11, 948

Nicola Acevedo,Peter Bosanac,Toni Pikoos,Susan Rossell,David Castle

DOI: https://doi.org/10.3390/brainsci12040450

IF: 3.333

2022-03-28

Brain Sciences

Abstract:The authors wish to correct the following error in this paper [...]

neurosciences
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Terence H. W. Ching,Lucia Amoroso,Calvin Bohner,Elizabeth D'Amico,Jeffrey Eilbott,Tara Entezar,Madison Fitzpatrick,Geena Fram,Rachael Grazioplene,Jamila Hokanson,Anastasia Jankovsky,Stephen A. Kichuk,Bradford Martins,Prerana Patel,Henry Schaer,Sarah Shnayder,Chelsea Witherow,Christopher Pittenger,Benjamin Kelmendi

DOI: https://doi.org/10.3389/fpsyt.2024.1372373

IF: 4.7

2024-02-17

Frontiers in Psychiatry

Abstract:This article is a correction to: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

psychiatry
Erratum: Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board

Frontiers Production Office

DOI: https://doi.org/10.3389/fmed.2024.1486408

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fmed.2024.1409259.].
Correction to "Revisiting the effectiveness of cognitive-behavioural therapy for reducing reoffending in the criminal justice system: A systematic review"

DOI: https://doi.org/10.1002/cl2.1438

2024-09-02

Abstract:[This corrects the article DOI: 10.1002/cl2.142.].
Corrigendum to “Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals” [Psychiatry Res. 186 (2–3) (2011) 437–440]

Hadas Gorodetzky,Barbara J. Sahakian,Trevor W. Robbins,Karen D. Ersche

DOI: https://doi.org/10.1016/j.psychres.2011.03.018

IF: 11.3

2011-01-01

Psychiatry Research

Abstract:Corrigendum to “Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals” [Psychiatry Res. 186 (2–3) (2011) 437–440] Hadas Gorodetzky , Barbara J. Sahakian , Trevor W. Robbins , Karen D. Ersche a,c,⁎ a University of Cambridge, Department of Psychiatry, Brain Mapping Unit, Cambridge, UK b University of Konstanz, Department of Psychology, Konstanz, Germany c University of Cambridge, Behavioural and Clinical Neuroscience Institute, Cambridge, UK d University of Cambridge, Department of Experimental Psychology, Cambridge, UK
Correction to "Enhancing the revelation of key genes and interaction networks in non-small cell lung cancer with major depressive disorder: A bioinformatics analysis"

DOI: https://doi.org/10.1002/hsr2.2290

2024-08-30

Abstract:[This corrects the article DOI: 10.1002/hsr2.2167.].
Publisher Correction: Structural neural plasticity evoked by rapid-acting antidepressant interventions

Clara Liao,Alisha N. Dua,Cassandra Wojtasiewicz,Conor Liston,Alex C. Kwan

DOI: https://doi.org/10.1038/s41583-024-00894-y

IF: 38.755

2024-12-13

Nature Reviews Neuroscience

Abstract:Nature Reviews Neuroscience, Published online: 12 December 2024; doi:10.1038/s41583-024-00894-y Publisher Correction: Structural neural plasticity evoked by rapid-acting antidepressant interventions

neurosciences
Corrigendum to 'Comment on: History repeating: guidelines to address common problems in psychedelic science'

DOI: https://doi.org/10.1177/20451253241263299

2024-08-19

Abstract:[This corrects the article DOI: 10.1177/20451253241243242.].
Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Tingting Jiang,Guan Wang,Yao Liu,Lu Feng,Meng Wang,Jie Liu,Yi Chen,Liang Ouyang

DOI: https://doi.org/10.1016/j.apsb.2022.02.028

IF: 14.903

2022-03-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.05.004.].

pharmacology & pharmacy
Correction: Cotovio et al. Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders. Brain Sci. 2023, 13, 1029

Gonçalo Cotovio,Fabiana Ventura,Daniel Rodrigues da Silva,Patrícia Pereira,Albino J. Oliveira-Maia

DOI: https://doi.org/10.3390/brainsci14020153

IF: 3.333

2024-02-03

Brain Sciences

Abstract:Brain Sciences, Vol. 14, Pages 153: Correction: Cotovio et al. Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders. Brain Sci. 2023, 13, 1029 Brain Sciences doi: 10.3390/brainsci14020153 Authors: Gonçalo Cotovio Fabiana Ventura Daniel Rodrigues da Silva Patrícia Pereira Albino J. Oliveira-Maia Missing Citation [...]

neurosciences
Correction: Amin et al. Hippocampal and Cerebellar Changes in Acute Restraint Stress and the Impact of Pretreatment with Ceftriaxone. Brain Sci. 2020, 10, 193

Shaimaa N. Amin,Sherif S. Hassan,Ahmed S. Khashaba,Magdy F. Youakim,Noha S. Abdel Latif,Laila A. Rashed,Hanan D. Yassa

DOI: https://doi.org/10.3390/brainsci14090933

IF: 3.333

2024-09-19

Brain Sciences

Abstract:Brain Sciences, Vol. 14, Pages 933: Correction: Amin et al. Hippocampal and Cerebellar Changes in Acute Restraint Stress and the Impact of Pretreatment with Ceftriaxone. Brain Sci. 2020, 10, 193 Brain Sciences doi: 10.3390/brainsci14090933 Authors: Shaimaa N. Amin Sherif S. Hassan Ahmed S. Khashaba Magdy F. Youakim Noha S. Abdel Latif Laila A. Rashed Hanan D. Yassa In the original publication [...]

neurosciences
Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]

Aleksander H. Erga,Guido Alves,Albert F.G. Leentjens

DOI: https://doi.org/10.1016/j.conctc.2023.101205

2023-08-01

Contemporary Clinical Trials Communications

Abstract:[This corrects the article DOI: 10.1016/j.conctc.2023.101080.].
Correction: Digital Psychotherapies for Adults Experiencing Depressive Symptoms: Systematic Review and Meta-Analysis

Joanna Omylinska-Thurston,Supritha Aithal,Shaun Liverpool,Rebecca Clark,Zoe Moula,January Wood,Laura Viliardos,Edgar Rodríguez-Dorans,Fleur Farish-Edwards,Ailsa Parsons,Mia Eisenstadt,Marcus Bull,Linda Dubrow-Marshall,Scott Thurston,Vicky Karkou

DOI: https://doi.org/10.2196/67439

2024-10-22

JMIR Mental Health

Abstract:Related Article Correction of: https://mental.jmir.org/2024/1/e55500

psychiatry
Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Charles Jennings,Rogier Landman,Yang Zhou,Jitendra Sharma,Julia Hyman,J Anthony Movshon,Zilong Qiu,Angela Roberts,Anna Wang Roe,Xiaoqin Wang,Huihui Zhou,Liping Wang,Feng Zhang,Robert Desimone,Guoping Feng

DOI: https://doi.org/10.1038/nn0717-1033b

IF: 25

2017-01-01

Nature Neuroscience

Abstract:Nat. Neurosci. 19, 1123–1130 (2016); published online 26 August 2016; corrected after print 29 August 2016 In the version of this article initially published online, the first author's name appears as “Charles Jennings” without middle initial; it has been changed to “Charles G Jennings”. Another author's name appears in the author list as “Angela Roberts,” also without middle initial; it has been changed to “Angela C Roberts.
Corrigendum: Early-Onset Depression in Stroke Patients: Effects on Unfavorable Outcome 5 Years Post-stroke

Ya-Ying Zeng,Meng-Xuan Wu,Sheng-Nan Zhou,Dan-Dan Geng,Lin Cheng,Kai-Li Fan,Xin Yu,Wen-Jie Tang,Jin-Cai He

DOI: https://doi.org/10.3389/fpsyt.2021.732437

IF: 4.7

2021-07-29

Frontiers in Psychiatry

Abstract:[This corrects the article DOI: 10.3389/fpsyt.2021.556981.].

psychiatry
Correction to "Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice"

DOI: https://doi.org/10.1002/npr2.12474

2024-08-28

Abstract:Amada N, Hirose T, Suzuki M, Kakumoto Y, Futamura T, Maeda K, et al. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacol Rep. 2023;43:132-136. In the 'Methods' section of the Abstract, the second sentence is as follows: "Escitalopram (10 mg/kg), fluoxetine (75 mg/kg), paroxetine (10 mg/kg), or sertraline (15 mg/kg) were orally administered to mice 60 min before testing." The amount listed for escitalopram is incorrect. It should be: 60 mg/kg. We apologize for this error.
Corrigendum: Behavioral and brain reactivity associated with drug-related and non-drug-related emotional stimuli in methamphetamine addicts

Xiawen Li,Yu Zhou,Guanghui Zhang,Yingzhi Lu,Chenglin Zhou,Hongbiao Wang

DOI: https://doi.org/10.3389/fnhum.2022.1032007

IF: 3.473

2022-09-14

Frontiers in Human Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnhum.2022.894911.].

psychology,neurosciences
Corrigendum: Study protocol for a randomized controlled trial of the RASPERA project: recalling and anticipating specific positive events to boost resilience in adolescents

Eline Loyen,Liesbeth Bogaert,David John Hallford,Arnaud D'Argembeau,Filip Raes

DOI: https://doi.org/10.3389/fpubh.2024.1360159

IF: 5.2

2024-01-29

Frontiers in Public Health

Abstract:[This corrects the article DOI: 10.3389/fpubh.2023.1216988.].

public, environmental & occupational health

Correction To: Time to Re-Engage Psychiatric Drug Discovery by Strengthening Confidence in Preclinical Psychopharmacology

Time to Re-Engage Psychiatric Drug Discovery by Strengthening Confidence in Preclinical Psychopharmacology

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia

Correction: Acevedo et al. Therapeutic Neurostimulation in Obsessive-Compulsive and Related Disorders: A Systematic Review. Brain Sci. 2021, 11, 948

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Erratum: Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board

Correction to "Revisiting the effectiveness of cognitive-behavioural therapy for reducing reoffending in the criminal justice system: A systematic review"

Corrigendum to “Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals” [Psychiatry Res. 186 (2–3) (2011) 437–440]

Correction to "Enhancing the revelation of key genes and interaction networks in non-small cell lung cancer with major depressive disorder: A bioinformatics analysis"

Publisher Correction: Structural neural plasticity evoked by rapid-acting antidepressant interventions

Corrigendum to 'Comment on: History repeating: guidelines to address common problems in psychedelic science'

Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Correction: Cotovio et al. Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders. Brain Sci. 2023, 13, 1029

Correction: Amin et al. Hippocampal and Cerebellar Changes in Acute Restraint Stress and the Impact of Pretreatment with Ceftriaxone. Brain Sci. 2020, 10, 193

Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]

Correction: Digital Psychotherapies for Adults Experiencing Depressive Symptoms: Systematic Review and Meta-Analysis

Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Corrigendum: Early-Onset Depression in Stroke Patients: Effects on Unfavorable Outcome 5 Years Post-stroke

Correction to "Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice"

Corrigendum: Behavioral and brain reactivity associated with drug-related and non-drug-related emotional stimuli in methamphetamine addicts

Corrigendum: Study protocol for a randomized controlled trial of the RASPERA project: recalling and anticipating specific positive events to boost resilience in adolescents